2025
Race Comparisons in Patients With Cardiac Sarcoidosis: Insights From the Cardiac Sarcoidosis Consortium.
Trongtorsak A, De La Rosa Martinez J, Crawford T, Bogun F, Gu X, Purroll E, Ellenbogen K, Chicos A, Roukoz H, Zimetbaum P, Kalbfleisch S, Murgatroyd F, Steckman D, Rosenfeld L, Soejima K, Bhan A, Vedantham V, Dickfeld T, De Lurgio D, Platonov P, Zipse M, Nishiuchi S, Ortman M, Narasimhan C, Patton K, Rosenthal D, Mukerji S, Hoogendoorn J, Zeppenfeld K, Torosoff M, Judson M, Martin K, Madias C, Hermel M, Nour K, Torbey E, Sauer W, Kron J. Race Comparisons in Patients With Cardiac Sarcoidosis: Insights From the Cardiac Sarcoidosis Consortium. Circulation Arrhythmia And Electrophysiology 2025, e013670. PMID: 40557494, DOI: 10.1161/circep.124.013670.Peer-Reviewed Original ResearchLeft ventricular ejection fractionCardiac sarcoidosisVentricular ejection fractionBlack patientsEjection fractionNo significant differenceClinical outcomesPrimary outcomeWhite patientsImplantable cardioverter defibrillator therapyLeft ventricular assist device implantationSignificant differenceVentricular assist device implantationComposite end pointChronic kidney diseaseChronic obstructive pulmonary diseaseAll-Cause MortalityAssist device implantationRates of lungRates of hypertensionObstructive pulmonary diseaseImplantable cardioverter defibrillatorExtracardiac involvementEye involvementHeart transplantationThe Impact and Safety of GLP‐1 Agents and Breast Cancer
Parsons K, Montalvo M, Fischbach N, Taylor M, Alfaro S, Lustberg M. The Impact and Safety of GLP‐1 Agents and Breast Cancer. Cancer Medicine 2025, 14: e70932. PMID: 40552446, PMCID: PMC12186097, DOI: 10.1002/cam4.70932.Peer-Reviewed Original ResearchConceptsBreast cancer patientsGLP-1 receptor agonistsBreast cancerBreast cancer-specific mortalityCancer patientsBreast cancer incidenceBreast cancer ratesWeight management interventionsProportion of breast cancer patientsNon-cancer populationObese post-menopausal womenReceptor agonistsBreast cancer outcomesBreast cancer progressionWeight loss interventionWeight management strategiesEffective weight managementGLP-1Quality of lifeAll-Cause MortalityCancer-specific mortalityImprove patient outcomesObesity prevalenceWeb of ScienceCancer incidenceTreatment outcomes of successful M1 versus M2 thrombectomy for low-ASPECTS stroke patients.
Chen H, Colasurdo M, Matsukawa H, Cunningham C, Maier I, Jabbour P, Kim J, Wolfe S, Rai A, Starke R, Psychogios M, Shaban A, Goyal N, Yoshimura S, Cuellar H, Howard B, Alawieh A, Alaraj A, Ezzeldin M, Romano D, Tanweer O, Mascitelli J, Fragata I, Polifka A, Siddiqui F, Osbun J, Crosa R, Grandhi R, Matouk C, Park M, Levitt M, Brinjikji W, Moss M, Daglioglu E, Williamson R, Navia P, Chowdhry S, Altschul D, Spiotta A, Kan P. Treatment outcomes of successful M1 versus M2 thrombectomy for low-ASPECTS stroke patients. Interventional Neuroradiology 2025, 15910199251343283. PMID: 40530425, PMCID: PMC12176791, DOI: 10.1177/15910199251343283.Peer-Reviewed Original ResearchLow Alberta Stroke Program Early CT ScoreAlberta Stroke Program Early CT ScoreEffect of endovascular thrombectomyM2 occlusionsIntracranial hemorrhageM2 patientsAssociated with intracranial hemorrhageOdds of all-cause mortalityMulticenter retrospective studyOdds of poor outcomeMultivariate logistic regression modelAll-Cause MortalityMiddle cerebral arteryStroke patientsM1 patientsM1 occlusionCT scoreRetrospective studyLogistic regression modelsPoor outcomeMultivariable adjustmentPrimary outcomeCerebral arteryTreatment outcomesEndovascular thrombectomySystematic Review and Meta‐Analysis of Dual‐Layered Stents Versus Single‐Layered Stents for Carotid Artery Stenosis
Mari T, Moeed A, Siddiqui A, Abbasi A, Arif Z, Jannat A, Akman Z, Rossi R, Unnar H, Bhatti H, Batool R, Khan M, Ali M, Batool F, Minahil, Iqbal J, Mena‐Hurtado C, Nanna M. Systematic Review and Meta‐Analysis of Dual‐Layered Stents Versus Single‐Layered Stents for Carotid Artery Stenosis. Catheterization And Cardiovascular Interventions 2025 PMID: 40518749, DOI: 10.1002/ccd.31684.Peer-Reviewed Original ResearchCarotid artery stentingCarotid artery stenosisSingle-layer stentsDual-layer stentsAll-Cause MortalityPost-procedural strokeArtery stenosisRandomized Controlled TrialsStent occlusionHigher risk of peri-procedural strokePostprocedural strokeMeta-analysisRisk of peri-procedural strokeRisk ratioHigh riskCarotid artery stenting proceduresStroke riskPeri-procedural strokeRandom-effects meta-analysisPredictors of strokeTreat carotid artery stenosisLipid-rich carotid plaquesTreatment optionsArtery stentingPrimary outcomeAll-Cause Mortality is Higher in Generalized Pustular Psoriasis (GPP) than Plaque Psoriasis and the General Population: A US-Based Claims Analysis.
Gottlieb A, Crooke Kwiatkowski H, Semeco J, Lakshminarasimhan B, Strober B, Lebwohl M. All-Cause Mortality is Higher in Generalized Pustular Psoriasis (GPP) than Plaque Psoriasis and the General Population: A US-Based Claims Analysis. Journal Of Psoriasis And Psoriatic Arthritis 2025, 24755303251344155. PMID: 40454110, PMCID: PMC12125009, DOI: 10.1177/24755303251344155.Peer-Reviewed Original ResearchAll-Cause MortalityGeneralized pustular psoriasisMortality riskGeneral populationMaximum follow-upFollow-upElevated mortality riskPlaque psoriasisPustular psoriasisAll-CauseMortality burdenClaims dataDays post-indexIndex dateMedical claimsPopulation of patientsObservational studyUS claims dataUS-basedPropensity score matchingCohortLimited literaturePost-indexBalance covariatesMortalityTrends of preemptive kidney transplantation in lupus compared to other primary diseases leading to end stage kidney disease in the United States of America
Contreras G, Pagan J, Elfassy T, Bandes M, Bustamante N, Ortigosa-Goggins M, Becerra L, Mendoza J, Drexler Y, Alonso S, Roth D. Trends of preemptive kidney transplantation in lupus compared to other primary diseases leading to end stage kidney disease in the United States of America. Lupus 2025, 34: 775-786. PMID: 40391526, DOI: 10.1177/09612033251344189.Peer-Reviewed Original ResearchConceptsKidney allograft failurePreemptive kidney transplantationEnd-stage kidney diseasePolycystic kidney diseaseRisk of kidney allograft failureAll-Cause MortalityUnited States Renal Data SystemNon-lupusGlomerular diseaseKidney diseaseDM recipientsLupus patientsKidney transplantationRisk of all-cause mortalityNon-lupus patientsEnd stage kidney diseaseIncident ESKD patientsStage kidney diseaseCochran-Armitage testAllograft failurePrimary diseasePoor outcomeHypertensionLupusPatientsAI-based volumetric six-tissue body composition quantification from CT cardiac attenuation scans for mortality prediction: a multicentre study
Yi J, Marcinkiewicz A, Shanbhag A, Miller R, Geers J, Zhang W, Killekar A, Manral N, Lemley M, Buchwald M, Kwiecinski J, Zhou J, Kavanagh P, Liang J, Builoff V, Ruddy T, Einstein A, Feher A, Miller E, Sinusas A, Berman D, Dey D, Slomka P. AI-based volumetric six-tissue body composition quantification from CT cardiac attenuation scans for mortality prediction: a multicentre study. The Lancet Digital Health 2025, 7: 100862. PMID: 40382274, PMCID: PMC12126277, DOI: 10.1016/j.landig.2025.02.002.Peer-Reviewed Original ResearchConceptsCT attenuation correctionEpicardial adipose tissueVisceral adipose tissuePrognostic valueAdipose tissuePerfusion imagingMedian follow-up timeHigher visceral adipose tissueIncreased all-cause mortality riskMuscle volume indexAttenuation correctionPredicting all-cause mortalityCardiac perfusion imagingKaplan-Meier curvesAll-cause mortality riskBody composition measurementsCox regression modelsAll-Cause MortalityReduced riskVolumetric measurementsIntramuscular adipose tissueMortality risk stratificationAI-based segmentationSubcutaneous adipose tissueIndex volumeDiabetes Status and Long-Term Mortality and Major Amputation Outcomes Following Revascularization in Chronic Limb Threatening Ischemia
Callegari S, Romain G, Aggarwal A, Cleman J, Smolderen K, Mena-Hurtado C. Diabetes Status and Long-Term Mortality and Major Amputation Outcomes Following Revascularization in Chronic Limb Threatening Ischemia. Journal Of Vascular Surgery 2025 PMID: 40348290, DOI: 10.1016/j.jvs.2025.04.065.Peer-Reviewed Original ResearchChronic limb-threatening ischemiaLower-extremity bypassSub-hazard ratiosPeripheral vascular interventionsDM statusRisk of deathLimb-threatening ischemiaTeam-based careShared decision-makingCumulative incidenceDiabetes mellitusMedicare claims dataCumulative incidence of mortalityAll-Cause MortalityType of revascularizationAmputation outcomesCare offerFine-Gray modelClaims dataCumulative incidence of deathLong-term mortalityMortality riskCox regression modelsHazard ratioDiabetes statusSocioeconomic area deprivation and its relationship with dementia, Parkinson's Disease and all-cause mortality among UK older adults: a multistate modeling approach
Beydoun M, Georgescu M, Weiss J, Noren Hooten N, Beydoun H, Tsai J, Maino Vieytes C, Evans M, Zonderman A. Socioeconomic area deprivation and its relationship with dementia, Parkinson's Disease and all-cause mortality among UK older adults: a multistate modeling approach. Social Science & Medicine 2025, 379: 118137. PMID: 40388863, DOI: 10.1016/j.socscimed.2025.118137.Peer-Reviewed Original ResearchConceptsArea-level deprivationTownsend deprivation indexSocioeconomic statusCardiovascular healthArea-level socioeconomic statusUK older adultsAll-Cause MortalityDementia deathsArea deprivationDeprivation indexUK BiobankCox proportional hazardsOlder adultsDementiaParkinson's diseasePD dementiaPotential mediatorsZ-scoreProportional hazardsMultistate modeling approachHealthMortalityMultistate modelWeibull regressionMultistate approachImmune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic Dysfunction
Chen Y, Dolladille C, Rao A, Palaskas N, Deswal A, Lehmann L, Cautela J, Courand P, Hayek S, Zhu H, Cheng R, Alexandre J, Baldassarre L, Roubille F, Laufer-Perl M, Asnani A, Ederhy S, Tamura Y, Francis S, Gaughan E, Johnson D, Flint D, Rainer P, Bailly G, Ewer S, Aras M, Arangalage D, Cariou E, Florido R, Peretto G, Zadok O, Akhter N, Narezkina A, Levenson J, Liu Y, Crusz S, Issa N, Piriou N, Leong D, Sandhu S, Turker I, Moliner P, Obeid M, Heinzerling L, Chang W, Stewart A, Venkatesh V, Du Z, Yadavalli A, Kim D, Chandra A, Zhang K, Power J, Moslehi J, Salem J, Zaha V, Registry I. Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic Dysfunction. JACC CardioOncology 2025, 7: 234-248. PMID: 40246381, PMCID: PMC12046861, DOI: 10.1016/j.jaccao.2025.01.020.Peer-Reviewed Original ResearchLeft ventricular ejection fractionImmune checkpoint inhibitorsPredictors of left ventricular ejection fractionAll-Cause MortalityHeart failureAssociated with 30-day all-cause mortalityDocumented LVEFAssociated with left ventricular ejection fractionReduced left ventricular ejection fractionImmune checkpoint inhibitor initiationImmune checkpoint inhibitor myocarditisHistory of heart failurePre-existing heart failureTransforming cancer treatmentVentricular ejection fractionCox proportional hazards modelsBody mass indexMultivariate logistic regressionTime of hospitalizationProportional hazards modelCheckpoint inhibitorsMyositis symptomsChest radiationCardiotoxic therapiesEjection fractionTarget Trial Emulation of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Versus No Infection and Risk of Post–Coronavirus Disease 2019 Conditions in the Omicron Variant Versus Prior Eras
Ioannou G, Berry K, Rajeevan N, Li Y, Yan L, Huang Y, Bui D, Hynes D, Rowneki M, Hickok A, Niederhausen M, Shahoumian T, Bohnert A, Boyko E, Korpak A, Fox A, Baraff A, Iwashyna T, Maciejewski M, Smith V, Berkowitz T, Pura J, Hebert P, Wong E, O’Hare A, Osborne T, Viglianti E, Aslan M, Bajema K. Target Trial Emulation of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Versus No Infection and Risk of Post–Coronavirus Disease 2019 Conditions in the Omicron Variant Versus Prior Eras. Clinical Infectious Diseases 2025, ciaf087. PMID: 40208261, DOI: 10.1093/cid/ciaf087.Peer-Reviewed Original ResearchPost-COVID-19 conditionCumulative incidence of deathVeterans Health AdministrationMatched index dateCumulative incidence differenceExcess burdenCumulative incidenceBurden of mortalityHypothetical target trialIncidence of deathDeath up to 1 yearTarget trial emulationAll-Cause MortalityHealth recordsHealth AdministrationTrial emulationIncidence differencesIndex dateUninfected participantsPost-coronavirus diseaseVeteransUnvaccinated personsTarget trialsOmicron eraVaccination statusCoronary artery bypass surgery improves restricted mean survival time in patients with ischemic cardiomyopathy
Reinhardt S, Huang H, Parise H, Ahmad T, Velazquez E, Faridi K. Coronary artery bypass surgery improves restricted mean survival time in patients with ischemic cardiomyopathy. American Heart Journal Plus Cardiology Research And Practice 2025, 54: 100538. PMID: 40485767, PMCID: PMC12142554, DOI: 10.1016/j.ahjo.2025.100538.Peer-Reviewed Original ResearchCoronary Artery Bypass GraftingAll-Cause MortalityIschemic cardiomyopathyMean survival timeMedical therapyRestricted mean survival timeClinical trialsEndpoint of all-cause mortalityInternational multicenter randomized clinical trialSurvival timeCoronary artery bypass surgeryOptimal medical therapyMulticenter Randomized Clinical TrialBenefit of coronary artery bypass graftingEffect of coronary artery bypass graftingIschemic heart failureArtery bypass surgeryCox proportional hazards modelsArtery Bypass GraftingRandomized clinical trialsProportional hazards modelSurgical treatmentBypass surgeryHeart failureBypass GraftingStandalone Middle Meningeal Artery Embolization Versus Conservative Management for Nontraumatic Subdural Hematoma
Chen H, Khunte M, Colasurdo M, Malhotra A, Gandhi D. Standalone Middle Meningeal Artery Embolization Versus Conservative Management for Nontraumatic Subdural Hematoma. Stroke 2025, 56: 1404-1412. PMID: 40177795, DOI: 10.1161/strokeaha.124.050190.Peer-Reviewed Original ResearchConceptsMiddle meningeal artery embolizationNontraumatic subdural hematomaRisk of all-cause mortalitySurgical rescueAll-Cause MortalitySubdural hematomaCM patientsConservative managementLow risk of deathSecondary end pointsRetrospective cohort studyFollow-up periodLong-term risk of all-cause mortalityTime-to-event analysisStandard of careNationwide Readmissions DatabaseRisk of deathNonacute subdural hematomasLong-term riskRandomized Controlled TrialsPropensity score matchingArtery embolizationSurgical evacuationCohort studyReadmissions DatabaseComparing major comorbidity indices as predictors of all-cause mortality in the Veterans Affairs health care system
Beydoun H, Szymkowiak D, Beydoun M, Nixdorff N, Brunner R, Tsai J. Comparing major comorbidity indices as predictors of all-cause mortality in the Veterans Affairs health care system. Journal Of Clinical Epidemiology 2025, 182: 111778. PMID: 40185292, PMCID: PMC12146076, DOI: 10.1016/j.jclinepi.2025.111778.Peer-Reviewed Original ResearchConceptsFunctional Comorbidity IndexUS Department of Veterans AffairsDepartment of Veterans AffairsFunctional Comorbidity Index scoresElixhauser Comorbidity IndexMeasures of comorbidityVeterans AffairsCharlson Comorbidity IndexHarrell's concordance statisticMortality riskNonhomeless veteransVeterans Affairs Health Care SystemComorbidity indexHomeless individualsHigh-risk patient populationVA healthcare servicesHigh riskClinical measuresHealth care servicesHealth care systemLow riskAll-Cause MortalityPatient populationAssociated with homelessnessPredictor of all-cause mortalityThe Association between All-Cause Mortality and Obstructive Sleep Apnea in Adults: A U-Shaped Curve.
Azarian M, Ramezani A, Sharafkhaneh A, Maghsoudi A, Kryger M, Thomas R, Westover M, Razjouyan J. The Association between All-Cause Mortality and Obstructive Sleep Apnea in Adults: A U-Shaped Curve. Annals Of The American Thoracic Society 2025, 22: 581-590. PMID: 39746198, PMCID: PMC12005042, DOI: 10.1513/annalsats.202407-755oc.Peer-Reviewed Original ResearchApnea-hypopnea indexAll-Cause MortalitySleep apneaBody mass indexAssociated with apnea-hypopnea indexApnea hypopnea index categoriesInterpretation of sleep studiesOdds ratioOdds of all-cause mortalityObstructive sleep apneaSeverity of SAAll-cause mortality ratesElixhauser Comorbidity IndexSleep studiesPropensity-matchedMass indexSevere SAComorbidity indexAll-CauseMortality rateMortalityEffects of ageApneaLogistic regressionAge groupsAll-Cause Mortality and Life Expectancy by Birth Cohort Across US States
Holford T, McKay L, Tam J, Jeon J, Meza R. All-Cause Mortality and Life Expectancy by Birth Cohort Across US States. JAMA Network Open 2025, 8: e257695. PMID: 40293748, PMCID: PMC12038512, DOI: 10.1001/jamanetworkopen.2025.7695.Peer-Reviewed Original ResearchConceptsBirth cohortYears of ageLife expectancyAge-period-cohort modelNational Center for Health StatisticsCenter for Health StatisticsCenters for Disease Control and PreventionUS mortality ratesDisease Control and PreventionPublic health interventionsCohort-specific patternsCohort life expectancyLower life expectancyControl and PreventionAll-Cause MortalityUS statesMortality rateOnline dataMortality trendsHealth interventionsHealth StatisticsMortality dataAll-CauseMain OutcomesCohort studyPost-Transcatheter Aortic Valve Replacement Antithrombotic Treatment in Nonindicated Patients Updated Systematic Review and Network Meta-Analysis
Siami S, Kazemian S, Maleki S, Ebrahimi E, Jodeiri F, Ebrahimzade M, Hajiqasemi M, Ebrahimi S, Mehdizadeh M, Aghaei M, Bastan M, Sabet M, Nazari R, Ebrahimi P, Rana J, Nanna M, Giri J, Kolte D, Biering-Sørensen T, Alkhouli M, Hosseini K. Post-Transcatheter Aortic Valve Replacement Antithrombotic Treatment in Nonindicated Patients Updated Systematic Review and Network Meta-Analysis. JACC Advances 2025, 4: 101719. PMID: 40286375, PMCID: PMC12049831, DOI: 10.1016/j.jacadv.2025.101719.Peer-Reviewed Original ResearchTranscatheter aortic valve replacementDual antiplatelet therapyOral anticoagulantsAntithrombotic regimensNetwork Meta-AnalysisAntiplatelet therapyCardiovascular mortalityMyocardial infarctionRisk of all-cause mortalityChronic oral anticoagulationAortic valve replacementMeta-analysisOptimal antithrombotic strategyIncreased risk of mortalityFrequentist network meta-analysisRisk of cardiovascular mortalityChronic obstructive pulmonary diseaseAll-Cause MortalityRisk of mortalityObstructive pulmonary diseaseBleeding riskValve replacementAntithrombotic treatmentNo significant differenceAntithrombotic strategies5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis
Forrest J, Yakubov S, Deeb G, Gada H, Mumtaz M, Ramlawi B, Bajwa T, Crouch J, Merhi W, Sang S, Kleiman N, Petrossian G, Robinson N, Sorajja P, Iskander A, Berthoumieu P, Tchétché D, Feindel C, Horlick E, Saito S, Oh J, Jung Y, Reardon M, Investigators L. 5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis. Journal Of The American College Of Cardiology 2025, 85: 1523-1532. PMID: 40158212, DOI: 10.1016/j.jacc.2025.03.004.Peer-Reviewed Original ResearchConceptsTranscatheter aortic valve replacementTranscatheter aortic valve replacement groupEvolut Low Risk trialEndpoint of all-cause mortalityAll-Cause MortalityNoninferior to surgeryLow-risk patientsAortic valve replacementSevere aortic stenosisSurgery groupKaplan-Meier estimatesLow-risk trialsAortic stenosisDisabling strokeValve replacementRisk trialsSurgical aortic valve replacementLost to follow-upRates of all-cause mortalityKansas City Cardiomyopathy Questionnaire summary scoreLow surgical riskQuestionnaire summary scoreQuality-of-life outcomesAttempted implantReintervention rateCardiovascular and Kidney Outcomes and Mortality With Long-Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Trials.
Lee M, Sattar N, Pop-Busui R, Deanfield J, Emerson S, Inzucchi S, Mann J, Marx N, Mulvagh S, Poulter N, Badve S, Pratley R, Perkovic V, Buse J, McGuire D. Cardiovascular and Kidney Outcomes and Mortality With Long-Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Trials. Diabetes Care 2025, 48: 846-859. PMID: 40156846, DOI: 10.2337/dc25-0241.Peer-Reviewed Original ResearchConceptsGlucagon-like peptide 1 receptor agonistsPeptide 1 receptor agonistsComposite kidney outcomeGLP-1RAAll-Cause MortalityType 2 diabetesKidney outcomesLong-actingOral formulationOutcome trialsHazard ratioReduced incidence of MACEIncidence rates of MACEIncreased risk of severe hypoglycemiaMeta-analysis of randomized trialsLong-acting GLP-1RASystematic review of PubMedWorsening kidney functionRisk of severe hypoglycemiaIncidence of MACERate of MACEEvaluate renal functionAdverse cardiovascular eventsCardiovascular outcome trialsReview of PubMedSevere Mitral Regurgitation in Paradoxical Low-Flow, Low-Gradient Severe Aortic Stenosis
Dahan S, Dal-Bianco J, Plakht Y, Namasivayam M, Capoulade R, Zeng X, Passeri J, Yucel E, Picard M, Levine R, Hung J. Severe Mitral Regurgitation in Paradoxical Low-Flow, Low-Gradient Severe Aortic Stenosis. Circulation Cardiovascular Imaging 2025, 18: e017598. PMID: 40116009, DOI: 10.1161/circimaging.124.017598.Peer-Reviewed Original ResearchConceptsLow-gradient severe aortic stenosisParadoxical low-flowSevere aortic stenosisAortic valve replacementPRESERVED LEFT VENTRICULAR EJECTION FRACTIONSevere mitral regurgitationSevere MRVentricular ejection fractionAortic stenosisMitral regurgitationAll-Cause MortalityValve replacementMR degreeEjection fractionComposite outcomeAortic valve replacement ratesAssociated with adverse outcomesComplexity to diagnosisIncreased left ventricular dimensionsLow transaortic gradientNon-severe MRSevere MR groupHeart failure hospitalizationPropensity-adjusted modelLeft ventricular remodeling
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply